Abstract
The ability of 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC), 3,5-diethoxycarbonyl-4-ethyl-1,4-dihydro-2,6-dimethylpyridine (EDDC) and griseofulvin to induce porphyria in primary cultures of mouse hepatocytes has been examined. Exposure of cultured mouse hepatocytes to DDC, EDDC or griseofulvin resulted in a marked inhibition of ferrochelatase which was sustained over the 4-day exposure period. Maximal concentrations of DDC (25 μM), EDDC (25 μM) and griseofulvin (25 μM) resulted in 14-fold, 30-fold and 9-fold increases, respectively, in total porphyrin in the culture medium. Analysis of the porphyrins accumulating indicated a predominance of protoporphyrin with all three xenobiotics. Addition of 5-aminolaevulinic acid (ALA) to mouse hepatocyte cultures (10–1000 μM) resulted in much larger increases (up to 164-fold) in porphyrin accumulation in the medium and the porphyrin accumulating was predominantly uroporphyrin. These studies have demonstrated that primary cultures of mouse hepatocytes provide a valid mechanism-based in vitro model of the hepatic porphyrias produced by the dihydropyridines and griseofulvin in mice.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abbritti G, De Matteis F (1971) Decreased levels of cytochrome P-450 and catalase in hepatic porphyria caused by substituted acetamides and barbiturates. Importance of the allyl group in the molecule of the active drugs. Chem Biol Interact 4: 281–286
Brady AM, Lock EA (1990) Induction of porphyria in primary mouse and rat hepatocyte cultures. Toxicologist 10 [1]: 296
Cole SPC, Massey TE, Marks GS, Racz WJ (1981a) Effects of porphyrin-inducing drugs on ferrochelatase activity in isolated mouse hepatocytes. Can J Physiol Pharmacol 59: 1155–1158
Cole SPC, Whitney RA, Marks GS (1981b) Ferrochelatase-inhibitory and porphyrin-inducing properties of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine and its analogues in chick embryo liver cells. Mol Pharmacol 20: 295–403
Cole SPC, Zelt DT, Marks GS (1981c) Comparison of the effects of griseofulvin and 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on ferrochelatase activity in chick embryo liver. Mol Pharmacol 19: 477–480
De Matteis F (1981) Increased hepatic production of porphyrins caused by drugs. In: Gorrod JW (ed) Testing for toxicity. Taylor and Francis, London, pp 173–184
De Matteis F, Gibbs AH (1975) Stimulation of the pathway of porphyrin synthesis in the liver of rats and mice by griseofulvin, 3,5-diethoxycarbonyl-1,4-dihydrocollidine and related drugs: evidence for two basically different mechanisms. Biochem J 146: 285–287
De Matteis F, Gibbs AH (1980) Drug induced conversion of liver haem into modified porphyrins: evidence for two classes of products. Biochem J 187: 285–288
De Matteis F, Prior BE (1962) Experimental hepatic porphyria caused by feeding 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine: comparison with sedormid porphyria. Biochem J 83: 1–8
De Matteis F, Rimmington C (1963) Disturbance of porphyrin metabolism caused by griseofulvin in mice. Br J Dermatol 75: 91–104
De Matteis F, Abbritti G, Gibbs AH (1973) Decreased liver activity of porphyrin-metal chelatase in hepatic porphyria caused by 3,5-diethoxycarbonyl-1,4-dihydrocollidine: studies in rats and mice. Biochem J 134: 717–727
De Matteis F, Gibbs AH, Tephly TR (1980) Inhibition of protohaem ferro-lyase in experimental porphyria. Biochem J 188: 145–152
De Matteis F, Gibbs AH, Farmer PB, Lamb JH (1981) Liver production of N-alkylated porphyrins in mice caused by treatment with substituted dihydropyridines. FEBS Lett 129: 328–331
De Matteis F, Hollands C, Gibbs AH, de Sa N, Rizzadini M (1982) Inactivation of cytochrome P-450 and production of N-alkylated porphyrins caused in isolated hepatocytes by substituted dihydropyridines. FEBS Lett 145: 87–92
Elder GH (1982) Enzymatic defects in porphyria: an overview. Semin Liver Dis 2 [part 2]: 87–99
Falk JE (1964) Special techniques. In: Porphyrins and metalloporphyrins. BBA Library Volume 2: 115–153
Famei L, Lim CK, Peters TJ (1987) An HPLC assay for rat liver ferrochelatase activity. Biomed Chromatogr 2: 164–168
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275
Marks GS (1978) The effect of chemicals on hepatic heme biosynthesis: differences in response to porphyrin-inducing chemicals between chick embryo liver cells, the 17-day old chick embryo and other species. In: Heme and hemoproteins: handbook of experimental pharmacology, De Matteis, WN Aldridge (eds), Springer-Verlag, Vol 44, pp 201–2327
Marks GS, Follows SB, Zelt DT, Cole SPC (1983) Patterns of porphyrin accumulation in response to chemicals in chick embryo liver cells. Can J Physiol Pharmacol 61: 546–558
Mitchell AM, Bridges JW, Elcombe CR (1984) Factors influencing peroxisome proliferation in cultured rat hepatocytes. Arch Toxicol 55: 239–246
Nebert DW, Nelson DR, Feyereisen R (1989) Evolution of the cytochrome P-450 genes. Xenobiotica 19: 1149–1160
Onisawa J, Labbe RF (1963) Effects of diethyl-1,4-dihydro-2,4,6-trimethylpyridine-3,5-dicarboxylate on the metabolism of porphyrins and iron. J Biol Chem 238: 724–727
Ortiz de Montellano PR, Correia MA (1983) Suicidal destruction of cytochrome P-450 during oxidative drug metabolism. Annu Rev Pharmacol Toxicol 23: 481–503
Ortiz de Montellano PR, Costa AK, Grab A, Sutherland EP, Marks GS (1986) Cytochrome P-450 destruction and ferrochelatase inhibition. In: Nordmann Y (ed) Porphyrins and porphyrias. Colloque INSERM/John Libbey Eurotext Ltd, Vol. 134: 109–117
Racz WJ, Marks GS (1969) Drug-induced porphyrin biosynthesis — II Simple procedure for screening drugs for porphyria-inducing activity. Biochem Pharmacol 18: 2009–2018
Weston Hurst E, Paget GE (1963) Protoporphyrin, cirrhosis and hepatomata in the livers of mice given griseofulvin. Br J Dermatol 75: 105–112
Zelt DT, Owen JA, Marks GS (1980) Second derivative high performance liquid chromatographic fluorimetric detection of porphyrins in chick embryo liver cell culture medium. J Chromatogr 189: 209–216
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brady, A.M., Lock, E.A. Inhibition of ferrochelatase and accumulation of porphyrins in mouse hepatocyte cultures exposed to porphyrinogenic chemicals. Arch Toxicol 66, 175–181 (1992). https://doi.org/10.1007/BF01974011
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01974011